Median Technologies SA (EPA:ALMDT)

France flag France · Delayed Price · Currency is EUR
5.43
-0.27 (-4.74%)
Jun 3, 2026, 5:37 PM CET
Market Cap217.38M +419.5%
Revenue (ttm)23.47M +2.2%
Net Income-34.07M
EPS-0.93
Shares Out 38.14M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume360,149
Open5.63
Previous Close5.70
Day's Range5.40 - 5.66
52-Week Range1.19 - 7.27
Beta0.57
AnalystsStrong Buy
Price Target12.97 (+138.86%)
Earnings DateSep 16, 2026

About Median Technologies

Median Technologies SA engages in providing medical imaging products and services for diagnosing and monitoring cancer patients in both routine clinical practice and clinical drug development with operations spanning in France, the United States, Canada, the United Kingdom, China, and internationally. The company offers iSee for imaging services in clinical trials; eyonis for non-invasive diagnostic tests based on imaging for the diagnosis and treatment of patients suffering from cancer; and iCRO, a central imaging service and AI-powered Imagin... [Read more]

Sector Healthcare
Founded 2002
Employees 199
Stock Exchange Euronext Paris
Ticker Symbol ALMDT
Full Company Profile

Financial Performance

In 2025, Median Technologies's revenue was 23.47 million, an increase of 2.22% compared to the previous year's 22.96 million. Losses were -34.07 million, 35.0% more than in 2024.

Financial Statements